导语: 诸多免疫组化书籍琳琅满目,看完未必会记得住。亲们在病理诊断工作中肯定有深切的感触,我们常常遇见转移而来的肿瘤,这些肿瘤形态各异,来源不定。大多数情况下,这些肿瘤可以结合患者病史、部位及相关临床检查结果明确诊断,而少数病例则缺乏可参考的临床资料,或是由于借助现有的医疗资源仍不能检出原发部位的疾病,这时可能就面临着免疫组化抗体的选择问题。拿几十种抗体当机关枪一顿猛扫?偏偏你没选择的抗体就有可能是阳性,再回首则打脸声不绝于耳,屡试不爽。 A 形态学可辨认 A1 CK7+ CK20- 肺腺癌:TTF-1+,NapsinA+,SP-A+/-,GATA3- 乳腺癌:GATA3+,ER+(髓样特征的癌则为-),GCDPF-15-/+,MGB(Mammaglobin)+/- 胃腺癌:CEA+,CDX2-/+,MUC1-/+,MUC5AC-/+,CDH17(Cadherin-17)+/- 食管腺癌:CEA+,CDX2-/+,MUC1-/+,MUC5AC-/+,CDH17(Cadherin-17)+/-,SATB2- 胰腺腺癌:DPC4(SMAD4)-/+,CK17 +/-,pVHL-,Maspin+,S100P+,IMP3+,MUC5AC+ 子宫颈腺癌:p16弥漫+,HPV原位杂交+,CEA+,PR-,PAX2-,PAX8 +/- 尿路上皮癌:GATA3+,p40+,p63+,S100P+,CK5/6+,CK903+,CK20 +/-,UPⅡ +/- 间皮瘤:Calretinin+,CEA-,WT1+,MOC-31-,D2-40+,TTF-1-,CK5/6+,TAG72-,Vimentin +/- 子宫内膜样腺癌:ER+,PAX8+,CEA-,Vimentin+,MGB(Mammaglobin)+/- 卵巢浆液性癌:PAX8+,ER+,TFF3-,WT1+,GATA3- 卵巢透明细胞癌:pVHL+,HNF-1β+,KIM-1(TIM-1)+ 胸腺癌:CD5+/-,p63+/-,PAX8+/- 涎腺导管癌:GATA3+,AR+,GCDPF-15+ 甲状腺髓样癌:TTF-1+,Calcitonin+,CEA+ 甲状腺乳头状癌、滤泡癌:PAX8+,TTF-1+,Thyroglobulin+ A2 CK7- CK20+ 结肠腺癌:SATB2+,CDH17(Cadherin-17)+,β-catenin +,MUC1-/+,MUC2+/-,CDX-2+,Villin+,MUC4+ 小肠腺癌:SATB2-/+,CDH17(Cadherin-17)+,MUC2+/-,CDX-2+,Villin+/-,MUC5AC+/- 膀胱腺癌:β-catenin 细胞膜+, CDH17(Cadherin-17)+ Merkel细胞癌:NSE+,CD56+,CK20(核旁点状阳),MCPyV 阑尾腺癌:CDH17(Cadherin-17)+, CDX-2+, SATB2+,MUC5AC+/- 涎腺小细胞癌:NSE+,CD56+,CK20+ A3 CK7+ CK20+ 胰腺腺癌:DPC4(SMAD4)-/+,pVHL-,Maspin+,S100P+,MUC5AC+,CK17+/- 胃腺癌:CEA+,CDX2-/+,MUC1-/+,MUC5AC+/-,SATB2- 食管腺癌:CDX2+/-,CEA+,MUC1-/+, MUC5AC+/-, SATB2- 卵巢黏液性癌:DPC4(SMAD4)+, CDX2+/-,CA125+ 尿路上皮癌:GATA3+,p63+,S100P+,p40+,CK5/6+,CK903+,CK20+/-,UPⅡ+/- 小肠腺癌:MUC5AC+/-, CDX2+,Viliin+/-,CDH17(Cadherin-17)+,SATB2-/+ 肺黏液腺癌:TTF-1-/+,CK7-/+,CDX2+/- A4 CK7- CK20- 结肠髓样癌:CDX2-/+,Calretinin+/-,TFF3+/-,SATB2+,CDH17(Cadherin-17)+,高度的微卫星不稳定性 神经内分泌癌:CD56+,CgA+,Syn 肾细胞癌:pVHL+,KIM-1(TIM-1)+,PAX8+,RCC+,CD10+ 肝细胞癌:Arginase-1+,HepPar-1+,Glypican-3+,CD10+,pCEA+ 肾上腺皮质腺瘤/腺癌:Mart-1+,Calretinin+,INH-A+,SF-1+ 精原细胞瘤:CD117,PLAP,OCT4,SALL4,CD30,NANOG,Glypican3 前列腺腺泡腺癌:PSA+,NKX3.1+,PSAP+,P504S+,ERG+/- 鳞状细胞癌:CK5/6+,p63+,p40+,CK903+,Desmin+/-,SOX2+ 参考文献: 1. 《迈新生物免疫组化&抗体2019-2020》 2. Fan Lin, Haiyan Liu,Immunohistochemistry in Undifferentiated Neoplasm/Tumor of Uncertain Origin. Arch Pathol Lab Med Vol 138, December 2014 本文作者:王晓璐 宜昌市中心人民医院病理科 |
|